Cargando…
Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen
BACKGROUND AND PURPOSE—: The benefit/risk analysis of hormone therapy in postmenopausal women is not straightforward and depends on cardiovascular disease. Evidence supports the safety of transdermal estrogens and the importance of progestogens for thrombotic risk. However, the differential associat...
Autores principales: | Canonico, Marianne, Carcaillon, Laure, Plu-Bureau, Geneviève, Oger, Emmanuel, Singh-Manoux, Archana, Tubert-Bitter, Pascale, Elbaz, Alexis, Scarabin, Pierre-Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927222/ https://www.ncbi.nlm.nih.gov/pubmed/27256671 http://dx.doi.org/10.1161/STROKEAHA.116.013052 |
Ejemplares similares
-
High Level of Plasma Estradiol as a New Predictor of Ischemic Arterial Disease in Older Postmenopausal Women: The Three-City Cohort Study
por: Scarabin-Carré, Valérie, et al.
Publicado: (2012) -
Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study
por: Ryan, Joanne, et al.
Publicado: (2012) -
Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease.
por: Plu-Bureau, G., et al.
Publicado: (1994) -
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
por: Moisan, Frédéric, et al.
Publicado: (2016) -
Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
por: Courtois, Émeline, et al.
Publicado: (2022)